Table 4. Ongoing trials worldwide for mixed types of peritoneal cancer.

Trial phase	Cancer type	Treatment arm	Control arm	Sponsor/country	Primary outcome	ECD
II	Gynecologic and gastrointestinal cancers	CyRS + HIPEC	N/A	Bay Area Gynecology Oncology, USA	Treatment response and quality of life	2016
II	Pseudomyxoma peritonei, colorectal, ovarian, and mesothelioma	CyRS + HIPEC	N/A	Oslo University Hospital, Norway	OS	2017
II	Colorectal, appendiceal, peritoneal mesothelioma, pseudomyxoma peritonei, and gastric	CyRS + HIPEC	N/A	Montefiore Medical Center, USA	Evaluation of the technical parameters	2024

ECD, estimated completion date; CyRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy; OS, overall survival.